Whittier Trust Co. of Nevada Inc. increased its stake in shares of West Pharmaceutical Services Inc. (NYSE:WST) by 13.1% during the second quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 5,148 shares of the medical instruments supplier’s stock after acquiring an additional 595 shares during the period. Whittier Trust Co. of Nevada Inc.’s holdings in West Pharmaceutical Services were worth $644,000 as of its most recent SEC filing.
Other large investors also recently modified their holdings of the company. Financial Gravity Wealth Inc. acquired a new stake in shares of West Pharmaceutical Services during the first quarter worth $25,000. Manchester Capital Management LLC bought a new position in West Pharmaceutical Services in the first quarter valued at $33,000. Quadrant Capital Group LLC grew its position in West Pharmaceutical Services by 208.7% in the first quarter. Quadrant Capital Group LLC now owns 318 shares of the medical instruments supplier’s stock valued at $32,000 after purchasing an additional 215 shares in the last quarter. Machina Capital S.A.S. bought a new position in West Pharmaceutical Services in the second quarter valued at $42,000. Finally, Icon Wealth Partners LLC bought a new position in West Pharmaceutical Services in the first quarter valued at $46,000. Institutional investors and hedge funds own 91.62% of the company’s stock.
A number of research analysts recently weighed in on WST shares. Bank of America raised shares of West Pharmaceutical Services from an “underperform” rating to a “neutral” rating in a research report on Friday, July 26th. Jefferies Financial Group downgraded shares of West Pharmaceutical Services from a “buy” rating to a “hold” rating and set a $122.00 target price for the company. in a research report on Wednesday, May 1st. Zacks Investment Research raised shares of West Pharmaceutical Services from a “hold” rating to a “strong-buy” rating and set a $158.00 target price for the company in a research report on Saturday. Finally, William Blair started coverage on shares of West Pharmaceutical Services in a research report on Tuesday, April 23rd. They issued an “outperform” rating and a $112.16 target price for the company. Two analysts have rated the stock with a hold rating, two have given a buy rating and one has given a strong buy rating to the stock. The company currently has an average rating of “Buy” and an average target price of $130.72.
West Pharmaceutical Services stock traded down $1.72 during mid-day trading on Friday, reaching $135.56. The company’s stock had a trading volume of 322,850 shares, compared to its average volume of 355,702. The stock has a market cap of $10.12 billion, a P/E ratio of 48.24, a price-to-earnings-growth ratio of 3.91 and a beta of 1.30. West Pharmaceutical Services Inc. has a 12 month low of $91.75 and a 12 month high of $139.59. The firm’s 50 day simple moving average is $125.39. The company has a debt-to-equity ratio of 0.18, a current ratio of 3.02 and a quick ratio of 2.13.
West Pharmaceutical Services (NYSE:WST) last announced its quarterly earnings data on Thursday, July 25th. The medical instruments supplier reported $0.89 EPS for the quarter, beating analysts’ consensus estimates of $0.72 by $0.17. West Pharmaceutical Services had a net margin of 12.94% and a return on equity of 16.93%. The company had revenue of $469.70 million during the quarter, compared to the consensus estimate of $459.90 million. During the same quarter last year, the firm posted $0.70 EPS. The company’s quarterly revenue was up 5.0% on a year-over-year basis. As a group, analysts predict that West Pharmaceutical Services Inc. will post 3.07 earnings per share for the current fiscal year.
The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, November 6th. Stockholders of record on Wednesday, October 23rd will be given a $0.15 dividend. This represents a $0.60 dividend on an annualized basis and a dividend yield of 0.44%. The ex-dividend date of this dividend is Tuesday, October 22nd. West Pharmaceutical Services’s dividend payout ratio (DPR) is presently 21.35%.
West Pharmaceutical Services Profile
West Pharmaceutical Services, Inc manufactures and sells containment and delivery systems for injectable drugs and healthcare products in the United States, Germany, France, Other European countries, South Korea, and internationally. The company operates through two segments, Proprietary Products and Contract-Manufactured Products.
Featured Article: Bollinger Bands
Receive News & Ratings for West Pharmaceutical Services Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for West Pharmaceutical Services and related companies with MarketBeat.com's FREE daily email newsletter.